Back to Browse Journals » International Journal of Nanomedicine » Volume 9 » Issue 1
Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures
Authors Blakney AK, Krogstad EA, Jiang YH, Woodrow KA
Received 31 January 2014
Accepted for publication 1 April 2014
Published 17 June 2014 Volume 2014:9(1) Pages 2967—2978
DOI https://doi.org/10.2147/IJN.S61664
Checked for plagiarism Yes
Review by Single-blind
Peer reviewer comments 2
Anna K Blakney, Emily A Krogstad, Yonghou H Jiang, Kim A Woodrow
Department of Bioengineering, University of Washington, Seattle, Washington, USA
Background: Electrospun drug-eluting fabrics have enormous potential for the delivery of physicochemically diverse drugs in combination by controlling the underlying material chemistry and fabric microarchitecture. However, the rationale for formulating drugs at high drug loading in the same or separate fibers is unknown but has important implications for product development and clinical applications.
Methods: Using a production-scale free-surface electrospinning instrument, we produced electrospun nanofibers with different microscale geometries for the co-delivery of tenofovir (TFV) and levonorgestrel (LNG) – two lead drug candidates for multipurpose prevention of HIV acquisition and unintended pregnancy. We investigated the in vitro drug release of TFV and LNG combinations from composites that deliver the two drugs from the same fiber (combined fibers) or from separate fibers in a stacked or interwoven architecture. For stacked composites, we also examined the role that fabric thickness has on drug-release kinetics. We also measured the cytotoxicity and antiviral activity of the drugs delivered alone and in combination.
Results: Herein, we report on the solution and processing parameters for the free-surface electrospinning of medical fabrics with controlled microarchitecture and high drug loading (up to 20 wt%). We observed that in vitro release of the highly water-soluble TFV, but not the water-insoluble LNG, was affected by composite microarchitecture, fabric thickness, and drug content. Finally, we showed that the drug-loaded nanofibers are noncytotoxic and that the antiviral activity of TFV is preserved through the electrospinning process and when combined with LNG.
Conclusion: Electrospun fabrics with high drug loading create multicomponent systems that benefit from the independent control of the nanofibrous microarchitecture. Our findings are significant because they will inform the design and production of composite electrospun fabrics for the co-delivery of physicochemically diverse drugs that may be useful for multipurpose prevention.
Keywords: co-delivery, electrospinning, antiretroviral, contraceptive, microbicide, multipurpose prevention technology
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Readers of this article also read:
Emerging and future therapies for hemophilia
Carr ME, Tortella BJ
Journal of Blood Medicine 2015, 6:245-255
Published Date: 3 September 2015
Molecular targets in arthritis and recent trends in nanotherapy
Roy K, Kanwar RK, Kanwar JR
International Journal of Nanomedicine 2015, 10:5407-5420
Published Date: 26 August 2015
Psoriasis in childhood: effective strategies to improve treatment adherence
Shah KN, Cortina S, Ernst MM, Kichler JC
Psoriasis: Targets and Therapy 2015, 5:43-54
Published Date: 16 March 2015
Design real-time reversal of tumor multidrug resistance cleverly with shortened carbon nanotubes
Wu P, Li S, Zhang H
Drug Design, Development and Therapy 2014, 8:2431-2438
Published Date: 5 December 2014
Is increasing the dose of Entecavir effective in partial virological responders?
Erturk A, Adnan Akdogan R, Parlak E, Cure E, Cumhur Cure M, Ozturk C
Drug Design, Development and Therapy 2014, 8:621-625
Published Date: 29 May 2014
Relapsed Hodgkin lymphoma in adolescents: focus on current high-dose chemotherapy and autologous stem cell transplant
Guilcher GM, Stewart DA
Clinical Oncology in Adolescents and Young Adults 2014, 4:1-12
Published Date: 8 May 2014
Controlled-release approaches towards the chemotherapy of tuberculosis
Saifullah B, Hussein MZ, Hussein Al Ali SH
International Journal of Nanomedicine 2012, 7:5451-5463
Published Date: 12 October 2012
True story about HIV: theory of viral sequestration and reserve infection
Barasa S
HIV/AIDS - Research and Palliative Care 2011, 3:125-133
Published Date: 8 December 2011
Treatment of acute otitis externa with ciprofloxacin otic 0.2% antibiotic ear solution
Mösges R, Nematian-Samani M, Eichel A
Therapeutics and Clinical Risk Management 2011, 7:325-326
Published Date: 27 July 2011
Current and developing therapeutic agents in the treatment of Chagas disease
Werner Apt
Drug Design, Development and Therapy 2010, 4:243-253
Published Date: 17 September 2010
